Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Oncocyte Corp (OCX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   8-K10-K10-K10-K10-K10-K10-K10-K
Net income  -72.9-64.1-29.9-22.4-15.8-19.4-11.2-8.7
Depreciation and amortization   [+] 4.20.40.30.60.60.40.3
Asset impairment charges    0.4 0.6   
Stock-based compensation   6.85.13.01.51.60.91.8
Deferred taxes   -9.3-1.3     
Change in working capital   [+] 3.18.12.75.8-0.72.32.3
Other operating activities   23.3-8.8-3.4-4.44.5 0.1
Cash from operations   -35.9-26.0-19.7-11.6-13.4-7.5-4.2
   
Capital expenditures   -2.2-1.2-0.90.0-0.1-0.1-0.5
Acquisitions   -11.7-6.5     
Other cash from investing    -4.0-11.5 0.9-0.10.8
Cash from investing   -14.0-11.7-12.40.00.8-0.20.3
   
Issuance of common stock, net   78.020.848.910.0  11.6
Option exercises   2.61.40.90.10.60.20.0
Other cash from financing   3.03.40.02.210.610.10.0
Cash from financing   78.422.847.912.110.09.911.7
   
Free cash flow   -38.2-27.2-20.6-11.7-13.5-7.6-4.7
        Per share (diluted)   ($0.43)($0.42)($0.40)($0.31)($0.45)($0.29)($0.23)
   
Cash paid for interest   0.10.20.20.10.10.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy